期刊文献+

猪囊尾蚴头节单链抗体-PE40重组载体的构建及表达

Expression and construction of Cysticercosis cellulosae scolex ScFv and PE40 recombinant vector
原文传递
导出
摘要 从绿脓杆菌ATCC27853菌株中提取基因组,PCR扩增PE40基因,与pMD18-T载体连接并转化感受态大肠杆菌JM109中,构建重组质粒pMD-PE40;经鉴定正确后将PE40基因插入抗猪囊尾蚴头节单链抗体基因重组质粒pMD-ScFv中,构建重组质粒pMD-ScFv-PE40,经酶切、电泳回收目的片段,并亚克隆到表达载体pET-28a中,构建重组表达载体pET-ScFv-PE40;鉴定后转化E.coliBL21,IPTG诱导后进行SDS-PAGE和Western-blotting验证。结果表明,试验成功构建了重组表达载体pET-ScFv-PE40,目的片段约为1 800 bp;Western blotting证明重组蛋白具有一定的反应原性,为重组免疫毒素的制备及动物保护性试验奠定了基础。 To construct recombinant vector pET-ScFv-PE40,the single-chain antibody gene of against Cysticercus cellulosae scolex and Pseudomonas aeruginosa exotoxin PE40 gene was connected,and subcloned into expression vector pET-28a.Then BL21/pET-ScFv-PE40 was induced for protein expression and analysis.The results showed the recombinant expression vector pET-ScFv-PE40 was constructed successfully.The expressed protein was about 68 000.Western-blotting indicated that recombinant protein has a significant reactionogenicity.The product could serve as a basis for preparating of recombinant immunotoxin and animal protection experiment.
出处 《中国兽医学报》 CAS CSCD 北大核心 2010年第8期1064-1066,共3页 Chinese Journal of Veterinary Science
基金 国家自然科学基金资助项目(30571396)
关键词 猪囊尾蚴头节 单链抗体 绿脓杆菌外毒素PE40 原核表达 Cysticercus cllulosae scolex ScFv Pseudomonas aeruginosa exotoxin PE40 prokaryotic expression
  • 相关文献

参考文献10

  • 1张西臣,赵权.动物寄生虫病学[M].吉林:吉林人民出版社,2005.
  • 2Chiron M F. Recombinant immunotoxins and chimeric toxins for targeted therapy in oncology[J]. Bull Caneer,1997,84(12) :1135-1140.
  • 3Kreitman R J, Pastan I. Immunotoxins for targeted cancer therapy [J]. Adv Drug Delivery Rev, 1998,31 (1) :53-58.
  • 4萨姆布鲁克 J,拉塞尔 D W.分子克隆实验指南[M].3版.黄培堂,王嘉玺,朱厚础,等译.北京:科学出版社,2002:96—99;1232—1236.
  • 5Siegall C B. Clinical evaluation of BR96 ScFv-PE40 immunotoxin therapy in canine models of spontaneously occurring invasive carcinoma [J]. Clin Cancer Res, 2005,11(2) :751-755.
  • 6Douglas C M. Exotoxin A of Pseudomonas'aeruginosa : substitution of glutamic acid 553 with aspartic acid drastically reduces toxicity and enzymatic activity [J]. Bacteriology, 1987,169:4967-4971.
  • 7罗良生,黄强.基因重组免疫毒素研究进展[J].国外医学(肿瘤学分册),2000,27(5):269-270. 被引量:8
  • 8Kreitman R J. Immunotoxins for cancer therapy [J]. Cuurent Opinion Immunotoxins, 1999,11 : 570-580.
  • 9Kretman R J,Pastan I. Immunotoxins in the treatment of hematologic malignancies [J]. Current Drug Targets,2006,7(10) : 1301-1311.
  • 10Scott N, Reynolds C B, Wright M J, et al. Single-chain Fv phage display propensity exhibits strong positive correlation with overall expression levels [J]. BMC Biotechnot, 2008 (8) :97.

二级参考文献10

  • 1Chadwick DE,Jean LF,Jamal N,et al. British Journal of Haematology . 1993
  • 2Pastan I. Biochimica et Biophysica Acta . 1997
  • 3Arora N,Masood R,Zheng T,et al. Cancer Research . 1999
  • 4Klimka A,Barth S,Matthey B,et al. British Journal of Cancer . 1999
  • 5Xu Y,Xu Q,Rosenblum MG,et al. Leukemia . 1996
  • 6Perentesis JP,Gunther R,Waurzyniak B,et al. Clinical Cancer Research . 1997
  • 7Davol P,Beitz JG,Mohler M,et al. Cancer . 1995
  • 8Debinski W,Pastan I. Clinical Cancer Research . 1995
  • 9Haggerty HG,Waner WA,Comereski CR,et al. Toxicologic Pathology . 1999
  • 10Saleh MN,LeMasitre CF,Kuzel TM,et al. Journal of the American Academy of Dermatology . 1998

共引文献146

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部